MedTrace Logo

Hepatic Histology and Metabolism Following Total Pancreatectomy and Pancreaticoduodenectomy

NCT03864744 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2021-10-04

No results posted yet for this study

Summary

The objective of the study is to investigate the development of NAFLD following total pancreatectomy and pancreaticoduodenectomy and to explore the histological and metabolic changes following the procedures.

Conditions

  • Total Pancreatectomy
  • Pancreaticoduodenectomy
  • Pancreatic Diabetes
  • Non-Alcoholic Fatty Liver Disease
  • Metabolic Complication
  • Diabetes Mellitus

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • University of Copenhagen

    collaborator OTHER

  • Herlev and Gentofte Hospital

    collaborator OTHER

  • Steno Diabetes Center Copenhagen

    lead OTHER

Principal Investigators

  • Filip Krag Knop, Professor · Steno Diabetes Center Copenhagen, Clinical metabolic physiology

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-30
Primary Completion
2022-08-30
Completion
2022-08-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03864744 on ClinicalTrials.gov